Advances in Biopharmaceutical Technology in India
back to index

 

Chapter 10:   Life Sciences Education in India

Abstract:
Indian culture is the core element of education, originating from the “Gurukul” model of education. When compared to other developing nations, literacy rates remain low in India; but India has greatly progressed its education system. In pre-independent India, innovations brought about the concept of scientific education, which has subsequently provided independent India with intellectual wealth, entrepreneurial opportunities, industrial growth, and employment generation. Thus, the study of Life Sciences has not been restricted to institutions and universities, but has progressed into a much broader field known as Research. Life Sciences are the sciences of life and of living organisms, including their structure, function, growth, origin, evolution, and distribution. The application of this science in this today’s world is known as Biotechnology. Life Sciences and Biotechnology are widely recognised as the next wave of the knowledge-based economy, creating new opportunities for societies and economics. The main domains of these fields are biology, biomedicine, and clinical medicine. Life Sciences apply to three key social sectors: agriculture, health, and primary education. To capitalize on life sciences and biotechnology, India is pursuing excellence and building infrastructure in life science training, and is also taking steps to amalgamate research and training. The author describes the number of universities, institutions, and life sciences education systems in India, as well as education consultants and the various research activities they carry out. Biotechnology has been beneficial in producing novel drugs, improving the quality and efficiency of end products, and increasing manufacturing yields. The applications are not limited to pharmaceutical industry; in fact, practically all areas of modern biology (Agro-technology, Environmental Biology, Medical Biotechnology, and Contract Research Organizations) are affected.

About the Authors:

Dr. Dipti Sawant, Ph.D., MBA, CCRA
Associate Manger
Chiltern International Pvt. Ltd.
Mumbai India


Dr. Dipti Sawant is working with Chiltern International Pvt. Ltd as the Associate Manager of Clinical Operations. She is a bioscience graduate with a postgraduate degree in Biochemistry, a PhD in Applied Biology, and she is an ACRP Certified Clinical Research Professional. She has also obtained an MBA degree in Personnel Management at New Port University. She has more than five years of experience in Clinical Research and has experience working with various therapeutic areas like Oncology, Nephrology, Dermatology, Neurology, Ophthalmology, Burns, Diabetes, Endocrinology, Anesthesia, and Hepatology. During her tenure as a PhD student, she was responsible in establishing the Biochemistry Laboratory and Radioimmunoassay Laboratory at Ayurveda Research Center in Seth GS Medical College and KEM Hospital, Parel, Mumbai, and was also in charge of the Animal House. To her credit, she has many publications in leading pharma magazines, newspapers, and international journals, and has also received Gufic Prize for Best Paper for one of her research projects.

back to index
Eric Langer
BioPlan Associates, Inc.
2275 Research Blvd, Suite 500
Rockville, MD 20850
Phone: 301-921-5979; Fax: 301-926-2455
E-Mail: info@bioplanassociates.com